Evidence map›Paper›PMID 33079624›Full record

ArticleGM crops & food2021

Crop Biotechnology and Product Stewardship.

Ruth Mbabazi, Muffy Koch, Karim Maredia, Joseph Guenthner

Abstract read
In one paragraph

Article in GM crops & food, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ruth MbabaziProfessor and Director of International Programs, College of Agriculture and Natural Resources, Michigan State University.ORCID https://orcid.org/0000-0003-0854-9324
Muffy KochSenior Regulatory Affairs Manager, Simplot Plant Sciences, J. R. Simplot Company , Boise, ID, USA.
Karim MarediaProfessor and Director of International Programs, College of Agriculture and Natural Resources, Michigan State University.
Joseph GuenthnerProfessor Emeritus University of Idaho , Moscow, ID, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Agricultural biotechnology is enhancing agricultural productivity, food security, and livelihoods globally. Some developing countries have established functional biosafety regulatory systems and have commercialized genetically modified (GM) crops. Release of GM crops requires enhanced capacity for regulatory compliance and product stewardship to help ensure sustainable use of biotechnology products. We conducted a survey of 66 stakeholders, mostly from Africa and Asia, in two-week international agricultural biotechnology short courses. Respondents showed knowledge of biotechnology benefits and expressed potential barriers to commercialization. They identified 16 crops in the "pipeline for commercialization." Stakeholders also shared ideas about how to build capacity for product stewardship. Product stewardship is a concept which requires each person in the product life cycle - innovators, scientists, and technology users, to share responsibility. This paper focuses on adoption of product stewardship for post-release management of GM crops which encompasses trait performance, resistance management, integrated pest management (IPM), good agricultural practices, high-quality seeds and planting material, intellectual property management, labeling, identity preservation, consumer acceptance, and effective marketing.

Indexed as

BiotechnologyCrops, AgriculturalAgricultureFood SupplyPlants, Genetically Modified

Identifiers

PMID33079624
PMCPMC7583480

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.